+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NEPHROPLUS

Nephrocare Health Services Share Price

 

 

Nephrocare Health Services live price: ₹673.10. It opened at ₹678 vs previous close ₹678; intraday high/low: ₹687/₹669. The 50 DMA stands at ₹647.30.

Nephrocare Health Services Performance

  • Today's Low
  • ₹669
  • Today's High
  • ₹687
  • 52 Week Low
  • ₹446
  • 52 Week High
  • ₹770
  • Open Price₹678
  • Previous Close₹678
  • Volume99,786
  • 50 DMA₹647.30
  • 100 DMA₹614.40
  • 200 DMA-

Nephrocare Health Services Chart

Investment Returns

  • Over 1 Month + 2.3%
  • Over 3 Month + 26.15%
  • Over 6 Month + 32.36%
  • Over 1 Year + 46.33%

Smart Investing Starts Here Start SIP with Nephrocare Health Services for Steady Growth!

Invest Now

Nephrocare Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 6,754
  • P/B Ratio
  • 6
  • Average True Range
  • 27
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.4
  • RSI
  • 55.18
  • MFI
  • 34.43

Latest Stock News Updates

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday, 12th August, 2026 at 10:00 A.M IST to discuss the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. A copy of the invitation is also attached for your information

Nephrocare Health Services Ltd - 544647 - Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 ,Inter Alia, To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication regarding Notice on 17th Annual General Meeting and information on remote e-voting.

Nephrocare Health Services Financials

Nephrocare Health Services Technicals

EMA & SMA

Current Price
₹673.10
-4.8 (-0.71%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 12
  • 20 Day
  • ₹657.60
  • 50 Day
  • ₹647.30
  • 100 Day
  • ₹614.40
  • 200 Day
  • -

Resistance and Support

676.2 Pivot Speed
  • R3 702.40
  • R2 694.70
  • R1 683.90
  • S1 665.40
  • S2 657.70
  • S3 646.90

Nephrocare Health Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-19 Audited Results
2026-02-10 Quarterly Results

Nephrocare Health Services Shareholding Pattern

63.85%
18.3%
8.78%
5.85%
3.2%

About Nephrocare Health Services

Nephrocare Health Services offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.(Source : 202512 Prospectus Page No: 18) View More
  • NSE Symbol
  • NEPHROPLUS
  • BSE Symbol
  • 544647
  • ISIN
  • INE428V01029

Similar Stocks to Nephrocare Health Services

Nephrocare Health Services FAQs

Nephrocare Health Services share price is ₹673 As on 26 July, 2026 | 14:07

The Market Cap of Nephrocare Health Services is ₹6753.9 Cr As on 26 July, 2026 | 14:07

The P/E ratio of Nephrocare Health Services is As on 26 July, 2026 | 14:07

The PB ratio of Nephrocare Health Services is 6 As on 26 July, 2026 | 14:07

The 52 week High & Low of Nephrocare Health Services is ₹769.8/₹446 respectively As on 26 July, 2026 | 14:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23